Trident Texofab Board Meeting for Q4/FY26 Results Adjourned to May 30

Trident Texofab Ltd's Board Meeting, originally scheduled for May 28, 2026, to consider and approve the Audited Standalone Financial Results for the quarter and year ended March 31, 2026, has been adjourned. The adjournment occurred because the Audit Committee did not approve the financial results due to delays in preparation of the financial statements. The Audit Committee meeting is now adjourned until May 30, 2026. Consequently, the Board Meeting has also been rescheduled to Saturday, May 30, 2026, to consider and approve the same financial results. The company also confirmed that the trading window for designated persons remains closed until 48 hours after the results are made public on the revised date.